Stopping GLP-1 medications too soon can lead to weight gain or regain, and may impact blood sugar regulation
Saran A, et al
The only treatment that has consistently demonstrated long-term success in managing obesity is metabolic surgery, says Tyler Cohn, MD, interim director, division of minimally invasive, bariatric and community general surgery at Loyola Medicine
A strategic approach considers total cost, reliability, and market fit
Your provider may recommend the Precision Peptide Genetic Test to clarify whether storage-related potency variations could influence your clinical response, supporting more personalized monitoring
GLP-1 Therapy for Obesity Management ADA 2026 Spotlight Could monthly GLP-1 therapy be the next major step in obesity management